A(9-26)INSL3 [439]



A(9-26)INSL3


SMILES CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O
InChIKey HHIHBEIJOBMKLZ-XYUOUADWSA-N
Sequence YCCLSGCTQQDLLTLCPY
HELM PEPTIDE1{Y.C.C.L.S.G.C.T.Q.Q.D.L.L.T.L.C.P.Y}$$$$

Chemical Properties

Hydrogen bond acceptors 31
Hydrogen bond donors 30
Rotatable bonds 61
Log P -7.663
Molecular weight (Da) 2022.9
Stereochemistry info partial


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

A(9-26)INSL3


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.